These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24161316)

  • 1. New therapeutic targets for calcific aortic valve stenosis: the lipoprotein(a)-lipoprotein-associated phospholipase A2-oxidized phospholipid axis.
    Hung MY; Witztum JL; Tsimikas S
    J Am Coll Cardiol; 2014 Feb; 63(5):478-80. PubMed ID: 24161316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization.
    Mahmut A; Boulanger MC; El Husseini D; Fournier D; Bouchareb R; Després JP; Pibarot P; Bossé Y; Mathieu P
    J Am Coll Cardiol; 2014 Feb; 63(5):460-9. PubMed ID: 24161325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans.
    Perrot N; Thériault S; Rigade S; Chen HY; Dina C; Martinsson A; Boekholdt SM; Capoulade R; Le Tourneau T; Messika-Zeitoun D; Engert JC; Wareham NJ; Clavel MA; Pibarot P; Smith JG; Schott JJ; Mathieu P; Bossé Y; Thanassoulis G; Arsenault BJ
    Heart; 2020 Sep; 106(18):1407-1412. PubMed ID: 32636298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcific Aortic Valve Stenosis and Atherosclerotic Calcification.
    de Oliveira Sá MPB; Cavalcanti LRP; Perazzo ÁM; Gomes RAF; Clavel MA; Pibarot P; Biondi-Zoccai G; Zhigalov K; Weymann A; Ruhparwar A; Lima RC
    Curr Atheroscler Rep; 2020 Jan; 22(2):2. PubMed ID: 31912380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.
    Sticchi E; Giusti B; Cordisco A; Gori AM; Sereni A; Sofi F; Mori F; Colonna S; Fugazzaro MP; Pepe G; Nistri S; Marcucci R
    Intern Emerg Med; 2019 Jan; 14(1):45-50. PubMed ID: 30099661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Ma GS; Wilkinson MJ; Reeves RR; Yeang C; DeMaria AN; Cotter B; Patel M; Mahmud E; Tsimikas S
    Angiology; 2019 Apr; 70(4):332-336. PubMed ID: 30700108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From the National Heart, Lung, and Blood Institute (NHLBI): researchers find gene variant linked to aortic valve disease.
    National Heart, Lung, and Blood Institute
    Ethn Dis; 2013; 23(3):388. PubMed ID: 23914433
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.
    Yeang C; Wilkinson MJ; Tsimikas S
    Curr Opin Cardiol; 2016 Jul; 31(4):440-50. PubMed ID: 27205885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.
    Guddeti RR; Patil S; Ahmed A; Sharma A; Aboeata A; Lavie CJ; Alla VM
    Prog Cardiovasc Dis; 2020; 63(4):496-502. PubMed ID: 32526213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.
    Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
    J Am Coll Cardiol; 2014 Feb; 63(5):470-7. PubMed ID: 24161338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study.
    Capoulade R; Mahmut A; Tastet L; Arsenault M; Bédard É; Dumesnil JG; Després JP; Larose É; Arsenault BJ; Bossé Y; Mathieu P; Pibarot P
    JACC Cardiovasc Imaging; 2015 Jan; 8(1):26-33. PubMed ID: 25499129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the ultimate test that lowering lipoprotein(a) is beneficial for cardiovascular disease and aortic stenosis?
    Hung MY; Tsimikas S
    Curr Opin Lipidol; 2014 Dec; 25(6):423-30. PubMed ID: 25340480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Threshold effect for lipoprotein(a) in aortic stenosis.
    Tzolos E; Dweck MR
    Heart; 2021 Sep; 107(17):1367-1368. PubMed ID: 34021037
    [No Abstract]   [Full Text] [Related]  

  • 14. New Frontiers in Lp(a)-Targeted Therapies.
    Borrelli MJ; Youssef A; Boffa MB; Koschinsky ML
    Trends Pharmacol Sci; 2019 Mar; 40(3):212-225. PubMed ID: 30732864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis.
    Tsimikas S
    Circ Res; 2019 Feb; 124(3):405-415. PubMed ID: 30702993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated phospholipase A2 and aortic stenosis: biomarker or new target for an old foe?
    Heistad D; Doshi H
    JACC Cardiovasc Imaging; 2015 Jan; 8(1):34-36. PubMed ID: 25592694
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.
    Capoulade R; Chan KL; Yeang C; Mathieu P; Bossé Y; Dumesnil JG; Tam JW; Teo KK; Mahmut A; Yang X; Witztum JL; Arsenault BJ; Després JP; Pibarot P; Tsimikas S
    J Am Coll Cardiol; 2015 Sep; 66(11):1236-1246. PubMed ID: 26361154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological significance of lipoprotein(a) in aortic valve stenosis.
    Yu B; Khan K; Hamid Q; Mardini A; Siddique A; Aguilar-Gonzalez LP; Makhoul G; Alaws H; Genest J; Thanassoulis G; Cecere R; Schwertani A
    Atherosclerosis; 2018 May; 272():168-174. PubMed ID: 29614432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease.
    Kaltoft M; Langsted A; Afzal S; Kamstrup PR; Nordestgaard BG
    J Am Coll Cardiol; 2022 Feb; 79(6):545-558. PubMed ID: 35144746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial cells in calcified aortic valves have reduced differentiation potential and stem cell-like properties.
    Bogdanova M; Zabirnyk A; Malashicheva A; Enayati KZ; Karlsen TA; Kaljusto ML; Kvitting JP; Dissen E; Sullivan GJ; Kostareva A; Stensløkken KO; Rutkovskiy A; Vaage J
    Sci Rep; 2019 Sep; 9(1):12934. PubMed ID: 31506459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.